Dow Up 1.31% Nasdaq Up 2.40%

Theravance Inc. (THRX)

-NasdaqGS
18.64 Up 0.69(3.84%) 4:00PM EDT
|After Hours : 18.64 0.00 (0.00%) 4:30PM EDT
Prev Close:17.95
Open:18.10
Bid:16.26 x 500
Ask:21.00 x 400
1y Target Est:28.71
Beta:1.12
Earnings Date:Oct 22 - Oct 27 (Est.)
Day's Range:17.63 - 18.68
52wk Range:15.76 - 32.89
Volume:1,075,307
Avg Vol (3m):842,432
Market Cap:2.14B
P/E (ttm):N/A
EPS (ttm):-2.09
Div & Yield:0.50 (2.90%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
THRXUp 3.84%2.14B
AZNUp 1.55%87.15B
CBSTDown 1.40%5.03B
PFEUp 1.25%179.32B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):910.27
Ex-Dividend Date:26-Aug-14

Analysts

Annual EPS Est (Dec-14) :-1.35
Quarterly EPS Est (Sep-14) :-0.14
Mean Recommendation*:2.7
PEG Ratio (5 yr expected):0.08

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Theravance, Inc., a royalty management company, is focused on developing respiratory products. It receives royalty revenues RELVAR/BREO ELLIPTA (fluticasone furoate/vilanterol, FF/VI), ANORO ELLIPTA (umeclidinium bromide/vilanterol, UMEC/VI), and ... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback